Annotation
Resume.
*
Goal.
Study the status of haemostasis in cardiac surgery patients with concomitant cholelithiasis for the selection of minimally invasive surgical interventions.
Material and methods.
All 34 patients examined were on anticoagulant and/or antiaggregant medication. To assess the status of the clotting system, blood sampling for analysis was performed in all patients 2 times a day before stopping the anticoagulant and/or antiaggregant taken, isocoagulation and surgery, as most patients had a hypocoagulable state at the time of admission to hospital. For the perioperative administration of patients, the 2018 clinical guideline of the Ministry of Health of the Russian Federation (Perioperative administration of patients receiving longterm antithrombotic therapy) was used. Twentyfour patients underwent cholecystectomy laparoscopically, the remaining 10 patients from mini access.
Results.
The mean values of the coagulation system before surgery were in a state of hypocoagulation, during and on the first day after surgery isocoagulation was noted and after taking anticoagulants and/or antiaggregant on the 3rd day after surgery the mean values were close to the initial parameters before surgery. The average duration of surgery for LCE was 63±13.5 min, and for cholecystectomy from mini access 65±15.7 min. There were no intraoperative and postoperative complications.
Conclusion.
Given the absence of intraand postoperative complications and the favourable outcome, minimally invasive cholecystectomy is the method of choice for patients undergoing cardiac surgery.
Keywords
Full text
List of literature
- 1. Амонов Ш.Ш., Олими М., Бокиев Ф.Б. Fast track хирургия — мультимодальная стратегия при калькулёзном холецистите у больных с клапанными и коронарными пороками. Здравоохранение Таджикистана. 2020; 2(345): 10-15.
- 2. Губергриц Н.Б., Губергриц Н.Б., Беляева Н.В., Клочков А.Е., Лукашевич Г.М., Фоменко П.Г. Снова о клинических «масках» желчнокаменной болезни. Гастроэнтерология Санкт-Петербурга. 2018; 3: 73-80.
- 3. Заболотских И.Б., Киров М.Ю., Афончиков В.С., Буланов А.Ю., Григорьев Е.В., Грицан А.И., Шулутко Е.М. Периоперационное ведение пациентов, получающих длительную антитромботическую терапию. Клинические рекомендации Федерации анестезиологов и реаниматологов. Вестник интенсивной терапии имени А.И. Салтанова. 2019; 1: 7-19. https://doi.org/10.21320/1818-474X-2019-1-7-19.
- 4. Красильников Д.М., Миргасимова Д.М., Абдулянов А.В., Шигабутдинов Р.Р., Захарова А.В. Осложнения при лапароскопической холецистэктомии. Инновационные технологии в медицине. Практическая медицина. 2016; 1(4(96)): 110-113.
- 5. Оганов Р.Г., Симаненков В.И., Бакулин И.Г., Бакулина Н.В., Барбараш О.Л., Бойцов С.А., Шальнова С.А. Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения. Кардиоваскулярная терапия и профилактика. 2019; 18(1): 5-66. https://doi.org/10.15829/1728-8800-2019-1-5-66.
- 6. Протасевич П.П., Якубцевич Р.Э. Обзор рекомендаций европейского общества анестезиологов по терапии периоперационного кровотечения с позиции доказательной медицины. Медицинские новости. 2016; 10(265): 21-26.
- 7. Шостак Н.А., Клименко А.А., Андрияшкина Д.Ю., Демидова Н.А. Антитромботическая терапия пациентов с клапанной болезнью сердца: что нового? Клиницист. 2017; 11(2): 10-15. https://doi.org/10.17650/1818-8338-2017-11-2-10-15.
- 8. Douketis J.D., Spyropoulos A.C., Spencer F.A., et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl): e326S-e350S.
- 9. Kozek-Langenecker S.A., Ahmed A.B., Afshari A., et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. European Journal of Anaesthesiology. 2017; 34(6): 332-395.
- 10. Kristensen S.D., Knuuti J., Saraste A., et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. European Heart Journal. 2014; 35(35): 2383-2431.
- 11. Fleisher L.A., Fleischmann K.E., Auerbach A.D., et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Journal of the American College of Cardiology. 2014; 64(22): e77-e137.
- 12. Baron T.H., Kamath P.S., McBane R.D. Management of antithrombotic therapy in patients undergoing invasive procedures. New England Journal of Medicine. 2013; 368(22): 2113-2124.
- 13. Doherty J.U., Gluckman T.J., Hucker W.J., et al. 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation. Journal of the American College of Cardiology. 2017; 69(7): 871-898.
- 14. Steffel J., Verhamme P., Potpara T.S., et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. European Heart Journal. 2018; 39(16): 1330-1393.
- 15. Valgimigli M., Bueno H., Byrne R.A., et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. European Heart Journal. 2018; 39(3): 213-260.